Literature DB >> 26778918

Confined crystallization of fenofibrate in nanoporous silica.

L M Dwyer1, V K Michaelis2, M O'Mahony1, R G Griffin2, A S Myerson1.   

Abstract

Producing stable nanocrystals confined to porous excipient media is a desirable way to increase the dissolution rate and improve the bioavailability of poorly water soluble pharmaceuticals. The poorly soluble pharmaceutical fenofibrate was crystallized in controlled pore glass (CPG) of 10 different pore sizes between 12 nm and 300 nm. High drug loadings of greater than 20 wt% were achieved across all pore sizes greater than 20 nm. Nanocrystalline fenofibrate was formed in pore sizes greater than 20 nm and showed characteristic melting point depressions following a Gibbs-Thomson relationship as well as enhanced dissolution rates. Solid-state Nuclear Magnetic Resonance (NMR) was employed to characterize the crystallinity of the confined molecules. These results help to advance the fundamental understanding of nanocrystallization in confined pores.

Entities:  

Year:  2015        PMID: 26778918      PMCID: PMC4711376          DOI: 10.1039/C5CE01148E

Source DB:  PubMed          Journal:  CrystEngComm        ISSN: 1466-8033            Impact factor:   3.545


  26 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution.

Authors:  Xiaoxia Chen; Timothy J Young; Marazban Sarkari; Robert O Williams; Keith P Johnston
Journal:  Int J Pharm       Date:  2002-08-21       Impact factor: 5.875

3.  Enhanced drug dissolution using evaporative precipitation into aqueous solution.

Authors:  Marazban Sarkari; Judith Brown; Xiaoxia Chen; Steve Swinnea; Robert O Williams; Keith P Johnston
Journal:  Int J Pharm       Date:  2002-08-28       Impact factor: 5.875

4.  Manipulating the crystalline state of pharmaceuticals by nanoconfinement.

Authors:  M Beiner; G T Rengarajan; S Pankaj; D Enke; M Steinhart
Journal:  Nano Lett       Date:  2007-04-17       Impact factor: 11.189

Review 5.  Solid state amorphization of pharmaceuticals.

Authors:  J F Willart; M Descamps
Journal:  Mol Pharm       Date:  2008 Nov-Dec       Impact factor: 4.939

6.  Crystallization under nanoscale confinement.

Authors:  Qi Jiang; Michael D Ward
Journal:  Chem Soc Rev       Date:  2013-10-01       Impact factor: 54.564

7.  Production of drug loaded microparticles by the use of supercritical gases with the aerosol solvent extraction system (ASES) process.

Authors:  J Bleich; B W Müller
Journal:  J Microencapsul       Date:  1996 Mar-Apr       Impact factor: 3.142

8.  Solid-state NMR characterization of high-loading solid solutions of API and excipients formed by electrospinning.

Authors:  Blair Brettmann; Erin Bell; Allan Myerson; Bernhardt Trout
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

Review 9.  Drug nanocrystals in the commercial pharmaceutical development process.

Authors:  Jan P Möschwitzer
Journal:  Int J Pharm       Date:  2012-09-21       Impact factor: 5.875

Review 10.  Nanocrystal technology, drug delivery and clinical applications.

Authors:  Jens-Uwe A H Junghanns; Rainer H Müller
Journal:  Int J Nanomedicine       Date:  2008
View more
  1 in total

1.  Design of Non-Haemolytic Nanoemulsions for Intravenous Administration of Hydrophobic APIs.

Authors:  Line Séguy; Anne-Claire Groo; Didier Goux; Didier Hennequin; Aurélie Malzert-Fréon
Journal:  Pharmaceutics       Date:  2020-11-25       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.